Literature DB >> 21346518

ApoE E4 is a susceptibility factor in amnestic but not aphasic dementias.

Emily Joy Rogalski1, Alfred Rademaker, Theresa M Harrison, Irene Helenowski, Nancy Johnson, Eileen Bigio, Manjari Mishra, Sandra Weintraub, Marek-Marsel Mesulam.   

Abstract

The goal of this study was to determine if the apolipoprotein ε gene, which is a well-established susceptibility factor for Alzheimer disease (AD) pathology in typical amnestic dementias, may also represent a risk factor in the language-based dementia, primary progressive aphasia (PPA). Apolipoprotein E genotyping was obtained from 149 patients with a clinical diagnosis of PPA, 330 cognitively healthy individuals (NC), and 179 patients with a clinical diagnosis of probable Alzheimer's disease (PrAD). Allele frequencies were compared among the groups. Analyses were also completed by sex and in 2 subsets of PPA patients: 1 in which the patients were classified by subtype (logopenic, agrammatic, and semantic) and another in which pathologic data were available. The allele frequencies for the PPA group (ε2:5%, ε3:79.5%, and ε4:15.4%) showed a distribution similar to the NC group, but significantly different from the PrAD group. The presence of an ε4 allele did not influence the age of symptom onset or aid in the prediction of AD pathology in PPA. These data show that ε4 polymorphism, which is a well-known risk factor for AD pathology in typical amnestic dementias, has no similar relationship to the clinical syndrome of PPA or its association with AD pathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21346518      PMCID: PMC3100354          DOI: 10.1097/WAD.0b013e318201f249

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  25 in total

1.  Apoe epsilon2-epsilon4 genotype is a possible risk factor for primary progressive aphasia.

Authors:  Adele Acciarri; Carlo Masullo; Alessandra Bizzarro; Alessandro Valenza; Davide Quaranta; Camillo Marra; Francesco D Tiziano; Christina Brahe; Davide Seripa; Maria G Matera; Vito M Fazio; Guido Gainotti; Antonio Daniele
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

2.  APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in women.

Authors:  Antonio Daniele; Maria G Matera; Davide Seripa; Adele Acciarri; Alessandra Bizzarro; Alberto Pilotto; Carlo Masullo
Journal:  Arch Neurol       Date:  2009-07

Review 3.  Primary progressive aphasia.

Authors:  M M Mesulam
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

4.  The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Authors:  John C Morris; Sandra Weintraub; Helena C Chui; Jeffrey Cummings; Charles Decarli; Steven Ferris; Norman L Foster; Douglas Galasko; Neill Graff-Radford; Elaine R Peskind; Duane Beekly; Erin M Ramos; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

5.  Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury.

Authors:  M Ariza; R Pueyo; M del M Matarín; C Junqué; M Mataró; I Clemente; P Moral; M A Poca; A Garnacho; J Sahuquillo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-13       Impact factor: 10.154

6.  Quantitative template for subtyping primary progressive aphasia.

Authors:  Marsel Mesulam; Christina Wieneke; Emily Rogalski; Derin Cobia; Cynthia Thompson; Sandra Weintraub
Journal:  Arch Neurol       Date:  2009-12

7.  Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.

Authors:  Gil D Rabinovici; William J Jagust; Ansgar J Furst; Jennifer M Ogar; Caroline A Racine; Elizabeth C Mormino; James P O'Neil; Rayhan A Lal; Nina F Dronkers; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

8.  Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum.

Authors:  R Migliaccio; F Agosta; K Rascovsky; A Karydas; S Bonasera; G D Rabinovici; B L Miller; M L Gorno-Tempini
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

9.  Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia.

Authors:  Marsel Mesulam; Alissa Wicklund; Nancy Johnson; Emily Rogalski; Gabriel C Léger; Alfred Rademaker; Sandra Weintraub; Eileen H Bigio
Journal:  Ann Neurol       Date:  2008-06       Impact factor: 10.422

10.  Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.

Authors:  Federica Agosta; Keith A Vossel; Bruce L Miller; Raffaella Migliaccio; Stephen J Bonasera; Massimo Filippi; Adam L Boxer; Anna Karydas; Katherine L Possin; Maria Luisa Gorno-Tempini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-22       Impact factor: 11.205

View more
  20 in total

Review 1.  Towards a clearer definition of logopenic progressive aphasia.

Authors:  Cristian E Leyton; John R Hodges
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

Review 2.  Pathology in primary progressive aphasia syndromes.

Authors:  Jennifer M Harris; Matthew Jones
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

Review 3.  Primary progressive aphasia: a model for neurodegenerative disease.

Authors:  Boon Lead Tee; Maria Luisa Gorno-Tempini
Journal:  Curr Opin Neurol       Date:  2019-04       Impact factor: 5.710

4.  Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer's disease presenting as logopenic progressive aphasia.

Authors:  Keith A Josephs; Dennis W Dickson; Melissa E Murray; Matthew L Senjem; Joseph E Parisi; Ronald C Petersen; Clifford R Jack; Jennifer L Whitwell
Journal:  Brain Lang       Date:  2013-03-28       Impact factor: 2.381

5.  APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia.

Authors:  Keith A Josephs; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Matthew L Senjem; Val J Lowe; Clifford R Jack; Jennifer L Whitwell
Journal:  Alzheimers Dement       Date:  2014-06-28       Impact factor: 21.566

6.  Biomarkers in the primary progressive aphasias.

Authors:  Murray Grossman
Journal:  Aphasiology       Date:  2014-09       Impact factor: 2.773

7.  Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.

Authors:  Irene Sintini; Jonathan Graff-Radford; Matthew L Senjem; Christopher G Schwarz; Mary M Machulda; Peter R Martin; David T Jones; Bradley F Boeve; David S Knopman; Kejal Kantarci; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

8.  Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features.

Authors:  Emily Rogalski; Jaiashre Sridhar; Benjamin Rader; Adam Martersteck; Kewei Chen; Derin Cobia; Cynthia K Thompson; Sandra Weintraub; Eileen H Bigio; M-Marsel Mesulam
Journal:  Neurology       Date:  2016-08-26       Impact factor: 9.910

Review 9.  Are there susceptibility factors for primary progressive aphasia?

Authors:  Emily Rogalski; Sandra Weintraub; M-Marsel Mesulam
Journal:  Brain Lang       Date:  2013-03-13       Impact factor: 2.381

10.  Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia.

Authors:  M-Marsel Mesulam; Sandra Weintraub; Emily J Rogalski; Christina Wieneke; Changiz Geula; Eileen H Bigio
Journal:  Brain       Date:  2014-02-25       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.